Donoghue Forlines LLC Abb Vie Inc. Transaction History

Donoghue Forlines LLC

$342 Million
Q3 2024

A detailed history of Donoghue Forlines LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Donoghue Forlines LLC holds 7,891 shares of ABBV stock, worth $1.42 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

7,891

Previous 7,615 3.62%

Holding current value

$1.42 Million

Previous $1.31 Million 19.3%

% of portfolio

0.46%

Previous 0.38%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $45,219 - $55,015	276 Added 3.62%	7,891 $1.56 Million
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $18,265 - $21,329	118 Added 1.57%	7,615 $1.31 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $223,428 - $254,575	1,398 Added 22.92%	7,497 $1.37 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $29,721 - $33,473	-216 Reduced 3.42%	6,099 $945,000
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $85,631 - $99,130	641 Added 11.3%	6,315 $941,000
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $307,688 - $382,897	2,322 Added 69.27%	5,674 $764,000
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $26,897 - $30,976	-186 Reduced 5.26%	3,352 $534,000
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $156,566 - $187,764	-1,132 Reduced 24.24%	3,538 $572,000
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $1.02 Million - $1.17 Million	-7,579 Reduced 61.87%	4,670 $627,000
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $533,552 - $678,319	-3,877 Reduced 24.04%	12,249 $1.88 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $407,686 - $505,823	3,089 Added 23.69%	16,126 $2.61 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $186,068 - $235,430	-1,732 Reduced 11.73%	13,037 $1.77 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $6,809 - $7,729	64 Added 0.44%	14,769 $1.59 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $35,771 - $39,851	340 Added 2.37%	14,705 $1.66 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $86,136 - $94,826	-842 Reduced 5.54%	14,365 $1.56 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $1.22 Million - $1.65 Million	15,207 New	15,207 $1.63 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $1.62 Million - $2.46 Million	-25,185 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $1.82 Million - $2.27 Million	25,185 New	25,185 $2.23 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $2.51 Million - $3.36 Million	-27,236 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $16.9 Million - $18.5 Million	-188,545 Reduced 87.38%	27,236 $2.63 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $1.01 Million - $1.29 Million	-14,477 Reduced 6.29%	215,781 $19.2 Million
Q2 2017 Sep 12, 2017	BUY	N/A	230,258	230,258 $16.7 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.

Account

Donoghue Forlines LLC Abb Vie Inc. Transaction History